Conjugated equine estrogens and peripheral arterial disease risk: The Women's Health Initiative
Open Access
- 1 July 2006
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 152 (1) , 170-176
- https://doi.org/10.1016/j.ahj.2005.09.005
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Risk of Cardiovascular Disease by Hysterectomy Status, With and Without OophorectomyCirculation, 2005
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Estrogen Plus Progestin and the Risk of Peripheral Arterial DiseaseCirculation, 2004
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in WomenCirculation, 2004
- Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?Annals of Medicine, 2004
- Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thicknessCoronary Artery Disease, 2003
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Vascular-Bed–Specific Hemostasis and Hypercoagulable StatesNew England Journal of Medicine, 1999
- Current estrogen-progestin and estrogen replacement therapy in elderly women: Association with carotid atherosclerosisAnnals of Epidemiology, 1996
- Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta.Journal of Clinical Investigation, 1991